In fact, GLI2 is reported to promote chemotherapy resistance via regulating HIF-1α and TGF-β2 in CRC [29], and it also enhances Hedgehog signaling to lead to GLI2-dependent drug tolerance in CRC [30]. Here, TGFB2 is linked to colorectal carcinoma.